Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: Aline Guillot, MD
Woman and Man Max 99 years
Aline Guillot, MD
Update Il y a 4 ans
Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma
The purpose of this study was to evaluate the safety and efficacy of CAP-232 in the treatment of patients with previously treated (refractory) renal cell carcinoma
Country
France
organs
None
Specialty
None
Closed trial
More information